Eva Hrubá

940 total citations
33 papers, 659 citations indexed

About

Eva Hrubá is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Clinical Biochemistry. According to data from OpenAlex, Eva Hrubá has authored 33 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Health, Toxicology and Mutagenesis and 8 papers in Clinical Biochemistry. Recurrent topics in Eva Hrubá's work include Metabolism and Genetic Disorders (8 papers), Carcinogens and Genotoxicity Assessment (6 papers) and Toxic Organic Pollutants Impact (6 papers). Eva Hrubá is often cited by papers focused on Metabolism and Genetic Disorders (8 papers), Carcinogens and Genotoxicity Assessment (6 papers) and Toxic Organic Pollutants Impact (6 papers). Eva Hrubá collaborates with scholars based in Czechia, United States and Slovakia. Eva Hrubá's co-authors include J Zeman, Martin Magner, Miroslav Machala, Vratislav Smolka, Tomáš Honzík, Miriam Adamovičová, Jan Vondráček, Amanda Janesick, Timo Hamers and Susanne Mandrup and has published in prestigious journals such as Environmental Science & Technology, Chemosphere and Journal of Bone and Mineral Research.

In The Last Decade

Eva Hrubá

32 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Hrubá Czechia 14 210 181 105 96 84 33 659
Ramadevi Gudi United States 19 431 2.1× 199 1.1× 75 0.7× 30 0.3× 84 1.0× 29 1.2k
Karin Tuschl United Kingdom 15 220 1.0× 508 2.8× 177 1.7× 89 0.9× 94 1.1× 26 1.2k
May Al‐Maghrebi Kuwait 17 387 1.8× 58 0.3× 108 1.0× 25 0.3× 36 0.4× 38 1.0k
Maria Wróbel Poland 20 371 1.8× 110 0.6× 158 1.5× 155 1.6× 17 0.2× 86 1.1k
Jing Shao China 19 287 1.4× 232 1.3× 95 0.9× 25 0.3× 30 0.4× 46 1.0k
Luciana C. Veiras United States 23 488 2.3× 42 0.2× 98 0.9× 24 0.3× 17 0.2× 34 1.2k
Shengmin Yan United States 17 263 1.3× 259 1.4× 126 1.2× 16 0.2× 29 0.3× 31 988
Lena Forsberg Sweden 12 498 2.4× 63 0.3× 80 0.8× 36 0.4× 66 0.8× 15 970
Céline Tomkiewicz France 19 492 2.3× 319 1.8× 134 1.3× 14 0.1× 20 0.2× 34 1.3k
N. Maeda United States 4 258 1.2× 84 0.5× 205 2.0× 22 0.2× 12 0.1× 5 703

Countries citing papers authored by Eva Hrubá

Since Specialization
Citations

This map shows the geographic impact of Eva Hrubá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hrubá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hrubá more than expected).

Fields of papers citing papers by Eva Hrubá

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hrubá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hrubá. The network helps show where Eva Hrubá may publish in the future.

Co-authorship network of co-authors of Eva Hrubá

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Hrubá. A scholar is included among the top collaborators of Eva Hrubá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Hrubá. Eva Hrubá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hrubá, Eva, et al.. (2025). Unveiling the cellular and molecular mechanisms of diabetic retinopathy with human retinal organoids. Cell Death and Disease. 16(1). 892–892.
2.
Shylo, Natalia A., Eva Hrubá, Tomáš Zikmund, et al.. (2023). Role of ciliopathy protein TMEM107 in eye development: insights from a mouse model and retinal organoid. Life Science Alliance. 6(12). e202302073–e202302073. 4 indexed citations
3.
Ševčíková, Tereza, Eva Hrubá, Jozef Škarda, et al.. (2023). Metastasising ameloblastoma or ameloblastic carcinoma? A case report with mutation analyses. BMC Oral Health. 23(1). 563–563. 2 indexed citations
4.
Skladaný, Ľubomír, et al.. (2021). Adherence to Oral Nutritional Supplements After Being Discharged from the Hospital is Low but Improves Outcome in Patients with Advanced Chronic Liver Disease. Patient Preference and Adherence. Volume 14. 2559–2572. 13 indexed citations
5.
Hrubá, Eva, Miloš Macholán, Tomáš Zikmund, et al.. (2021). Loss of Sprouty Produces a Ciliopathic Skeletal Phenotype in Mice Through Upregulation of Hedgehog Signaling. Journal of Bone and Mineral Research. 36(11). 2258–2274. 4 indexed citations
6.
Hýžďalová, Martina, Jiřina Procházková, Radek Fedr, et al.. (2020). A prolonged exposure of human lung carcinoma epithelial cells to benzo[a]pyrene induces p21-dependent epithelial-to-mesenchymal transition (EMT)-like phenotype. Chemosphere. 263. 128126–128126. 10 indexed citations
7.
Procházková, Jiřina, Zdeněk Andrysík, Martina Hýžďalová, et al.. (2018). Adaptive changes in global gene expression profile of lung carcinoma A549 cells acutely exposed to distinct types of AhR ligands. Toxicology Letters. 292. 162–174. 22 indexed citations
8.
Pěnčíková, Kateřina, Eva Hrubá, Lenka Pálková, et al.. (2017). Atropisomers of 2,2′,3,3′,6,6′-hexachlorobiphenyl (PCB 136) exhibit stereoselective effects on activation of nuclear receptors in vitro. Environmental Science and Pollution Research. 25(17). 16411–16419. 10 indexed citations
9.
Korábečný, Jan, Rafael Doležal, Anna Horova, et al.. (2014). 7-MEOTA–donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies. European Journal of Medicinal Chemistry. 82. 426–438. 71 indexed citations
10.
Hrubá, Eva, Zuzana Pernicová, Lenka Pálková, et al.. (2014). Phthalates Deregulate Cell Proliferation, but Not Neuroendocrine Transdifferentiation, in Human LNCaP Prostate Cancer Cell Model. Folia Biologica. 60. S56–S61. 8 indexed citations
11.
Procházková, Jiřina, Jiřı́ Pachernı́k, Jiří Kohoutek, et al.. (2013). Aryl Hydrocarbon Receptor Negatively Regulates Expression of the Plakoglobin Gene (Jup). Toxicological Sciences. 134(2). 258–270. 15 indexed citations
12.
Staršíchová, Andrea, Eva Hrubá, Eva Slabáková, et al.. (2012). TGF-β1 signaling plays a dominant role in the crosstalk between TGF-β1 and the aryl hydrocarbon receptor ligand in prostate epithelial cells. Cellular Signalling. 24(8). 1665–1676. 16 indexed citations
13.
Hrubá, Eva, Soňa Marvanová, Pavel Krčmář, et al.. (2012). Genotoxicity of 7H-dibenzo[c,g]carbazole and its methyl derivatives in human keratinocytes. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 743(1-2). 91–98. 6 indexed citations
14.
Hrubá, Eva, Jan Vondráček, Helena Líbalová, et al.. (2011). Gene expression changes in human prostate carcinoma cells exposed to genotoxic and nongenotoxic aryl hydrocarbon receptor ligands. Toxicology Letters. 206(2). 178–188. 38 indexed citations
15.
Gábelová, Alena, Eva Hrubá, Soňa Marvanová, et al.. (2011). Genotoxicity of 7H-dibenzo[c,g]carbazole and its tissue-specific derivatives in human hepatoma HepG2 cells is related to CYP1A1/1A2 expression. Environmental and Molecular Mutagenesis. 52(8). 636–645. 8 indexed citations
16.
Hrubá, Eva, Soňa Marvanová, Pavel Krčmář, et al.. (2010). Genotoxic polycyclic aromatic hydrocarbons fail to induce the p53-dependent DNA damage response, apoptosis or cell-cycle arrest in human prostate carcinoma LNCaP cells. Toxicology Letters. 197(3). 227–235. 26 indexed citations
17.
Valík, Dalibor, et al.. (2004). Acute hyperammonaemic encephalopathy in a female newborn caused by a novel, de novo mutation in the ornithine transcarbamylase gene. Acta Paediatrica. 93(5). 710–711. 3 indexed citations
18.
Azevedo, Luı́sa, Martin Hřebı́ček, Eva Hrubá, et al.. (2003). New polymorphic sites within ornithine transcarbamylase gene: population genetics studies and implications for diagnosis. Molecular Genetics and Metabolism. 78(2). 152–157. 9 indexed citations
19.
Hrubá, Eva, et al.. (2001). [Metabolic complications and neurologic manifestations of vitamin B12 deficiency in children of vegetarian mothers].. PubMed. 140(23). 732–5. 7 indexed citations
20.
Zeman, J, H Houst'ková, Hana Hansíková, et al.. (1999). [Various manifestations of the A8344G mtDNA heteroplasmic mutation in 4 families with the MERRF syndrome].. PubMed. 138(13). 401–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026